Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AGC Biologics and Horizon Therapeutics plc Expand Partnership 2020-10-30 03:17
ZAGENO Acclaimed by Frost & Sullivan for Simplifying the Biotech Purchasing Process with Its Intuitive eCommerce Platform 2020-10-29 21:00
Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide 2020-10-29 20:00
Complete Data from Connect Biopharma's Phase 1b Study of CBP-201 Demonstrate Rapid, Early and Continuous Improvement in Patient Quality of Life and Atopic Dermatitis (AD) Symptoms 2020-10-29 19:00
Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment 2020-10-29 18:24
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa 2020-10-29 17:00
Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity 2020-10-29 09:57
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia 2020-10-29 09:35
Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center 2020-10-29 08:38
Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies 2020-10-28 21:00
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition 2020-10-28 07:00
Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history 2020-10-27 20:00
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China 2020-10-27 08:13
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) 2020-10-27 07:23
Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis 2020-10-26 19:40
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus 2020-10-26 16:35
RhoVac Participates in BIO Europe Digital 2020-10-26 16:26
1 236 237 238 239 240 415